We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Multiple companies have announced they will allow Apotex to manufacture patented HIV drugs for use in a fixed-dose combination product to be exported to Rwanda under Canada’s Access to Medicines Regime.